PTCT

PTC Therapeutics, Inc.

46
Fundamentals24/ 100
Valuation50/ 100
Upside potential57/ 100
Risk potential22/ 100

PTCT lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.

PTCT Fundamentals

MetricStatus
Under pressure
Under pressure
Under pressure
Strong

PTCT's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.

PTCT PE Valuation

PTCT has no meaningful PE right now: it lost money over the past year.

PTCT Forward outlook

MetricOutlook
--
Strong growth
Growth
Strongly improving
Limited
Low

Analysts expect earnings and revenue growth for PTCT, with profitability improving. However, they disagree widely on these estimates.

PTCT Risk to reward

ScenarioChangePrice
Upside+29%$81.98
Downside-22%$49.23

Calculated from the latest close: $63.36 on Nov 12.

PTCT's one-year upside scenario is somewhat larger than its downside: +29% against −22%.

PTCT Earnings Per Share

Q4 2023: $-8.37Q1 2024: $-7.69Q2 2024: $-6.32Q3 2024: $-5.95Q4 2024: $-4.73Q1 2025: $6.51Q2 2025: $6.97Q3 2025: $8.56Q4 2025: $7.78Q1 2026: $-2.29Q2 2026: $-0.54Q3 2026: $-1.36Forward: $1.88
Q4 2023: $-8.37Q1 2024: $-7.69Q2 2024: $-6.32Q3 2024: $-5.95Q4 2024: $-4.73Q1 2025: $6.51Q2 2025: $6.97Q3 2025: $8.56Q4 2025: $7.78Q1 2026: $-2.29Q2 2026: $-0.54Q3 2026: $-1.36Forward: $1.88
QuarterTTM EPSYoY
Forward$1.88—
Q3 2026-$1.36-116%
Q2 2026-$0.54-108%
Q1 2026-$2.29-135%
Q4 2025$7.78+$12.51
Q3 2025$8.56+$14.51
Q2 2025$6.97+$13.29
Q1 2025$6.51+$14.20
Q4 2024-$4.73+$3.64

PTCT has swung to a loss: it lost $1.36 per share over the past year, after a profit the year before.

PTCT Quarterly Revenue

Q4 2023: $307MQ1 2024: $210MQ2 2024: $187MQ3 2024: $197MQ4 2024: $213MQ1 2025: $1.2BQ2 2025: $179MQ3 2025: $211MQ4 2025: $165MQ1 2026: $273MQ2 2026: $361MQ3 2026: $358M
Q4 2023: $307MQ1 2024: $210MQ2 2024: $187MQ3 2024: $197MQ4 2024: $213MQ1 2025: $1.2BQ2 2025: $179MQ3 2025: $211MQ4 2025: $165MQ1 2026: $273MQ2 2026: $361MQ3 2026: $358M
QuarterRevenueYoY
Q3 2026$357.8M+70%
Q2 2026$360.5M+102%
Q1 2026$272.6M-77%
Q4 2025$164.7M-23%
Q3 2025$211M+7.2%
Q2 2025$178.9M-4.2%
Q1 2025$1.2B+460%
Q4 2024$213.2M-31%

PTCT's revenue is recovering but still below its 2025 peak: $358M last quarter, up 70% from the same quarter a year ago.

PTCT Free Cash Flow

Q4 2023: −$106MQ1 2024: $61MQ2 2024: −$64MQ3 2024: −$78MQ4 2024: −$34MQ1 2025: $868MQ2 2025: −$60MQ3 2025: −$70MQ4 2025: −$37MQ1 2026: −$60MQ2 2026: $127MQ3 2026: −$28M
Q4 2023: −$106MQ1 2024: $61MQ2 2024: −$64MQ3 2024: −$78MQ4 2024: −$34MQ1 2025: $868MQ2 2025: −$60MQ3 2025: −$70MQ4 2025: −$37MQ1 2026: −$60MQ2 2026: $127MQ3 2026: −$28M
QuarterFree cash flowYoY
Q3 2026-$28M+$41.8M
Q2 2026$126.9M+$186.6M
Q1 2026-$60.2M-107%
Q4 2025-$36.6M-$2.9M
Q3 2025-$69.7M+$7.8M
Q2 2025-$59.7M+$4.4M
Q1 2025$868.4M+1320%
Q4 2024-$33.8M+$72.1M

PTCT has burned cash in almost every quarter: $2M over the past year, down 100% from the year before.

PTCT Total Shares

Q4 2023: 75MQ1 2024: 76MQ2 2024: 77MQ3 2024: 77MQ4 2024: 77MQ1 2025: 86MQ2 2025: 78MQ3 2025: 87MQ4 2025: 88MQ1 2026: 83MQ2 2026: 92MQ3 2026: 83M
Q4 2023: 75MQ1 2024: 76MQ2 2024: 77MQ3 2024: 77MQ4 2024: 77MQ1 2025: 86MQ2 2025: 78MQ3 2025: 87MQ4 2025: 88MQ1 2026: 83MQ2 2026: 92MQ3 2026: 83M
PeriodChange %Net change
Quarterly-9.3%-8.5M shares
1 year-4.2%-3.6M shares
3 years+11%+8.1M shares
5 years+18%+12.9M shares
Available history+42%+24.6M shares

PTCT has 83M diluted shares, down 4.2% from a year ago.

PTCT Net Leverage

Q2 2024: -51.7xQ3 2024: -15.8xQ1 2025: -1.6xQ2 2025: -1.0xQ3 2025: -0.5xQ4 2025: -0.8xQ2 2026: -2.5xQ3 2026: 0.1x
Q2 2024: -51.7xQ3 2024: -15.8xQ1 2025: -1.6xQ2 2025: -1.0xQ3 2025: -0.5xQ4 2025: -0.8xQ2 2026: -2.5xQ3 2026: 0.1x
QuarterNet LeverageStatus
Q3 20260.1xVery low
Q2 2026-2.5xNet Cash
Q4 2025-0.8xNet Cash
Q3 2025-0.5xNet Cash
Q2 2025-1.0xNet Cash
Q1 2025-1.6xNet Cash
Q3 2024-15.8xNet Cash
Q2 2024-51.7xNet Cash

PTCT's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.

PTCT Weekly Momentum

MetricValueStatus
RSI44.2Neutral
Stochastic24.9Neutral

PTCT's weekly RSI is 44 (neutral) and its Stochastic is 25 (neutral).

PTCT PE vs Healthcare Sector

MetricPTCTSector medianRelative
PEN/A26x—

PTCT has no meaningful PE right now: it lost money over the past year.

PTCT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$62.41.5% above
20 week MA$68.87.9% below
50 week MA$70.911% below
100 week MA$62.31.7% above
200 week MA$49.129% above

PTCT's trend is mixed: it's above three of its five weekly moving averages, and 29% above its 200-week average.

PTCT Yearly ROI

YearStart priceEnd priceROI
2020$48.8$65.1+33%
2021$65.1$41.9-36%
2022$41.9$36.5-13%
2023$36.5$27.6-24%
2024$27.6$45.2+64%
2025$45.2$78.6+74%
2026 YTD$78.6$63.4-19%

PTCT has finished lower in three of the last six years. It's down 19% so far in 2026.

Give your agent the market.

Get API key